HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE
Report
- Report Number
- 2025587-2008-00052
- Event Type
- Injury
- Date Received
- July 8, 2008
- Date of Event
- May 13, 2008
- Report Date
- May 28, 2008
- Manufacturer
- MEDTRONIC HEART VALVES, INC.
- Product Code
- LWR
- PMA / PMN Number
- P980043
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
EVAL: DEVICE HISTORY REVIEWED. RESULTS: DEVICE HISTORY REVIEW FOUND THE PRODUCT MET SPECS WHEN RELEASED FOR DISTRIBUTION. ANALYSIS: RECEIVED IN VERY LITTLE CLEAR SOLUTION IN AN OPAQUE WHITE SPECIMEN CONTAINER ENCLOSED IN A SMALL PLASTIC BAG WRAPPED IN A LARGER PLASTIC BAG. ALL LEAFLETS ARE STIFF EXCEPT WHERE MINERALIZATION IS NOT PRESENT. EXTENSIVE TISSUE DETERIORATION RESULTING IN TEARS AND ABRASIONS DUE TO CONTACT WITH MINERALIZATION IS VISIBLE ON ALL CUSPS. REMNANTS OF GLISTENING OFF WHITE PANNUS REMAIN ATTACHED ADJACENT TO THE LEFT AND RIGHT CUSP MARGINS OF ATTACHMENT. RADIOGRAPHY SHOWS EXTENSIVE MINERALIZATION IN THE NON-CORONARY CUSP THAT EXTENDS ONTO THE FREE MARGIN AND BELLIES OF THE LEFT AND RIGHT CUSPS. CONCLUSION: REDUCED PERFORMANCE OF THE DEVICE DUE TO MINERALIZATION, A CONDITION ATTRIBUTED TO THE PT. DEVICE EXPLANTED AND REPLACED WITH NO REPORTED ADVERSE PT EFFECTS.
MEDTRONIC RECEIVED INFO THAT THIS BIOPROSTHETIC AORTIC VALVE EXHIBITED HIGH GRADIENTS AND INSUFFICIENCY. THE DECISION WAS MADE TO EXPLANT THE VALVE. UPON EXPLANT, CALCIFICATION DEPOSITS WERE OBSERVED ON ALL VALVE LEAFLETS. ASSOCIATED WITH THE CALCIFICATION WERE SMALL HOLES WITH JAGGED BORDERS, INDICATIVE OF DEGRADATION DUE TO CALCIFICATION. THE OPERATIVE REPORT INDICATES THE DYSFUNCTION WAS TRIGGERED BY ENDOCARDITIS WHICH THE PT DEVELOPED IN 2007. THE VALVE WAS EXPLANTED AND REPLACED WITH NO REPORTED ADVERSE PT EFFECTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE | LWR | MEDTRONIC HEART VALVES, INC. | T505 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK | Hospitalization| R |